DOCSLIB.ORG

Supplementary Data Genbank Or OSE Vs RO NIA Accession Gene Name Symbol FC B-Value H3073C09 11.38 5.62 H3126B09 9.64 6.44 H3073B0

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Data Genbank Or OSE Vs RO NIA Accession Gene Name Symbol FC B-Value H3073C09 11.38 5.62 H3126B09 9.64 6.44 H3073B0 Supplementary Data GenBank or OSE vs RO NIA accession Gene name Symbol FC B-value H3073C09 11.38 5.62 H3126B09 9.64 6.44 H3073B08 9.62 5.59 AU022767 Exportin 4 Xpo4 9.62 6.64 H3073B09 9.59 6.48 BG063925 Metallothionein 2 Mt2 9.23 18.89 H3064B07 9.21 6.10 H3073D08 8.28 6.10 AU021923 Jagged 1 Jag1 7.89 5.93 H3070D08 7.54 4.58 BG085110 Cysteine-rich protein 1 (intestinal) Crip1 6.23 16.40 BG063004 Lectin, galactose binding, soluble 1 Lgals1 5.95 10.36 BG069712 5.92 2.34 BG076976 Transcribed locus, strongly similar to NP_032521.1 lectin, galactose binding, soluble 1 5.64 8.36 BG062930 DNA segment, Chr 11, Wayne State University 99, expressed D11Wsu99e 5.63 8.76 BG086474 Insulin-like growth factor binding protein 5 Igfbp5 5.50 15.95 H3002d11 5.13 20.77 BG064706 Keratin complex 1, acidic, gene 19 Krt1-19 5.06 9.07 H3007A09 5.05 2.46 H3065F02 4.84 5.43 BG081752 4.81 1.25 H3010E09 4.71 11.90 H3064c11 4.43 1.00 BG069711 Transmembrane 4 superfamily member 9 Tm4sf9 4.29 1.23 BG077072 Actin, beta, cytoplasmic Actb 4.29 3.01 BG079788 Hemoglobin alpha, adult chain 1 Hba-a1 4.26 6.63 BG076798 4.23 0.80 BG074344 Mesothelin Msln 4.22 6.97 C78835 Actin, beta, cytoplasmic Actb 4.16 3.02 BG067531 4.15 1.61 BG073468 Hemoglobin alpha, adult chain 1 Hba-a1 4.10 6.23 H3154H07 4.08 5.38 AW550167 3.95 5.66 H3121B01 3.94 5.94 H3124f12 3.94 5.64 BG073608 Hemoglobin alpha, adult chain 1 Hba-a1 3.84 5.32 BG073617 Hemoglobin alpha, adult chain 1 Hba-a1 3.84 5.75 BG072574 Hemoglobin alpha, adult chain 1 Hba-a1 3.82 5.93 BG072211 Tumor necrosis factor receptor superfamily, member 19 Tnfrsf19 3.80 9.75 AW551388 Hemoglobin alpha, adult chain 1 Hba-a1 3.74 5.70 H3045D08 3.72 5.25 BG087267 Retinoic acid receptor responder (tazarotene induced) 2 Rarres2 3.70 5.59 BG073471 Hemoglobin alpha, adult chain 1 Hba-a1 3.68 5.37 BG068578 Villin 2 Vil2 3.68 9.88 BG086203 Hemoglobin alpha, adult chain 1 Hba-a1 3.67 5.87 BG078905 Myelin basic protein Mbp 3.67 11.22 BG063722 Actin, beta, cytoplasmic Actb 3.67 2.12 BG073467 Hemoglobin alpha, adult chain 1 Hba-a1 3.63 5.70 BG087671 Growth arrest specific 1 Gas1 3.61 8.38 H3120f11 3.60 7.05 H3113H09 3.56 5.69 BG063737 3.56 2.54 BG086202 Hemoglobin alpha, adult chain 1 Hba-a1 3.55 5.37 BG074904 Hemoglobin alpha, adult chain 1 Hba-a1 3.49 4.77 BG087899 Platelet derived growth factor, alpha Pdgfa 3.47 9.79 BG088319 Inactive X specific transcripts Xist 3.39 2.47 C77408 Transcribed locus, strongly similar to XP_424503.1 type II alpha keratin IIA [Gallus gallus] 3.36 5.00 BG086243 3.33 5.15 BG076355 Signal transducer and activator of transcription 3 Stat3 3.31 3.78 AU018835 Claudin 10 Cldn10 3.30 4.42 H3045e11 3.29 1.55 BG084265 Protein tyrosine phosphatase, receptor-type, F interacting protein, bindinPpfibp2 3.25 8.43 H3118G01 3.21 1.94 BG072651 RIKEN cDNA 4833418N17 gene Bnc1 3.21 7.08 BG077966 Keratin complex 1, acidic, gene 18 Krt1-18 3.20 4.78 H3117B08 3.19 4.39 H3134E01 3.17 0.91 H3130e10 3.16 2.20 H3032F06 3.15 1.19 BG072760 Hemoglobin alpha, adult chain 1 Hba-a1 3.11 4.18 BG067527 3.07 0.14 BG074443 Lectin, galactose binding, soluble 7 Lgals7 3.07 4.64 BG075648 Serine (or cysteine) proteinase inhibitor, clade G, member 1 Serping1 3.04 7.38 BG073469 Hemoglobin alpha, adult chain 1 Hba-a1 3.00 3.89 BG073053 Protein tyrosine phosphatase, receptor type, F Ptprf 3.00 1.52 BG072990 Hemoglobin Z, beta-like embryonic chain Hbb-bh1 3.00 0.35 AW548291 2.98 1.18 BG085433 Hemoglobin Z, beta-like embryonic chain Hbb-bh1 2.98 0.59 H3057H09 2.95 2.91 BG074644 Periplakin Ppl 2.92 5.10 BG065276 Podocalyxin-like Podxl 2.86 3.81 H3118d11 2.80 4.40 BG086422 Hemoglobin alpha, adult chain 1 Hba-a1 2.79 4.23 H3158A04 2.79 6.17 H3021d11 2.78 9.66 BG073869 Liver-specific bHLH-Zip transcription factor Lisch7 2.77 7.62 H3125F06 2.72 15.03 BG078395 Lymphocyte antigen 6 complex, locus E Ly6e 2.70 5.65 BG063937 Aminolevulinate, delta-, dehydratase Alad 2.67 5.02 BG070884 CDNA sequence BC037006 BC037006 2.67 12.69 H3016F08 2.66 16.22 BG077678 Actin, beta, cytoplasmic Actb 2.64 4.70 AU045358 Similar to potassium channel regulator 1 AU045404 2.61 3.66 BG070279 Polycystic kidney and hepatic disease 1-like 1 Pkhd1l1 2.60 8.09 BG075864 Procollagen, type VI, alpha 2 Col6a2 2.60 2.00 BG065443 Transcribed locus, strongly similar to XP_424503.1 type II alpha keratin IIA [Gallus gallus] 2.59 1.02 H3101A05 2.57 9.15 BG072761 Midkine Mdk 2.57 4.43 BG077677 Actin, beta, cytoplasmic Actb 2.56 4.84 BG072869 Empty spiracles homolog 2 (Drosophila) Emx2 2.56 6.20 BG070102 Putative homeodomain transcription factor 1 Phtf1 2.55 3.30 BG067921 Olfactory receptor 56 Olfr56 2.55 2.95 BG086115 Homeo box B3 Hoxb3 2.53 6.33 BG070071 Heat shock protein 1 Hspb1 2.53 2.34 BG070089 Tumor-associated calcium signal transducer 1 Tacstd1 2.52 6.00 BG088727 Villin 2 Vil2 2.51 8.44 BG086488 Hemoglobin alpha, adult chain 1 Hba-a1 2.51 3.24 AW552546 Aldehyde dehydrogenase family 1, subfamily A2 Aldh1a2 2.50 1.18 BG087171 Complement component 1, r subcomponent C1r 2.49 11.82 H3088C07 2.47 6.34 BG064854 Low density lipoprotein receptor-related protein 2 Lrp2 2.46 4.90 BG075073 Thymosin, beta 4, X chromosome Tmsb4x 2.45 8.25 H3160g04 2.41 4.04 BG063301 2.39 0.19 BG076054 Fibroblast growth factor receptor 1 Fgfr1 2.39 8.78 BG078478 RIKEN cDNA D230050J18 gene Gpc3 2.38 5.94 H3045A07 2.37 5.19 BG067753 FERM domain containing 4B Frmd4b 2.36 2.58 H3149d11 2.33 1.87 BG066193 WW domain containing transcription regulator 1 Wwtr1 2.32 7.63 BG086278 Pleiotrophin Ptn 2.32 5.28 BG073613 Insulin-like growth factor 2 Igf2 2.31 6.04 BG063105 TAP binding protein Tapbp 2.29 8.07 BG064815 Insulin-like growth factor 2 Igf2 2.29 3.38 H3072E04 2.28 5.30 H3003E06 2.28 0.04 H3047E05 2.27 0.74 BG085818 Hemoglobin alpha, adult chain 1 Hba-a1 2.27 5.82 BG079455 Adenine phosphoribosyl transferase Aprt 2.26 4.47 AW550270 Tenascin C Tnc 2.26 8.00 BG077818 Metallothionein 1 Mt1 2.26 5.23 BG086718 Villin 2 Vil2 2.24 4.97 H3097a11 2.23 1.24 BG086084 Wingless-related MMTV integration site 4 Wnt4 2.23 0.51 BG077167 Transcribed locus, strongly similar to XP_540869.1 similar to Finkel-Biskis-Reilly murine sarc 2.23 1.86 BG075105 Smoothened homolog (Drosophila) Smo 2.23 7.30 BG076331 Matrix metalloproteinase 2 Mmp2 2.22 2.03 BG078514 Transcribed locus, strongly similar to NP_062718.1 nuclear receptor coactivator 4 [Mus musc 2.22 2.09 BG086950 RIKEN cDNA 4933434E20 gene 4933434E20Rik 2.21 0.34 H3160d11 2.20 7.00 BG078926 Cystatin C Cst3 2.17 0.21 BG085962 Gelsolin Gsn 2.14 0.90 BG084919 Rab acceptor 1 (prenylated) Rabac1 2.13 3.98 BG065758 Transmembrane 4 superfamily member 3 Tm4sf3 2.13 7.47 AW551408 Sorting nexin 5 Snx5 2.12 1.18 H3107A05 2.12 8.42 BG071093 RIKEN cDNA D930036F22 gene D930036F22Rik 2.11 1.03 BG069459 RIKEN cDNA 4930402E16 gene 4930402E16Rik 2.11 4.47 BG077567 Trans-acting transcription factor 1 Sp1 2.11 0.69 BG078173 Phosphatidylinositol binding clathrin assembly protein Picalm 2.11 5.23 BG066200 Solute carrier family 9 (sodium/hydrogen exchanger), isoform 3 regulato Slc9a3r1 2.11 2.59 BG070934 Deiodinase, iodothyronine type III Dio3as 2.11 2.24 BG071905 RIKEN cDNA 2410003B16 gene 2410003B16Rik 2.10 0.14 H3051C09 2.10 7.54 BG071354 Cortactin binding protein 2 Cttnbp2 2.10 2.95 AW548440 2.08 3.85 H3127b10 2.08 1.46 BG086598 Zinc finger protein 36, C3H type-like 1 Zfp36l1 2.08 0.38 BG082636 Shroom Shrm 2.08 5.95 BG068694 Nucleoporin 155 Nup155 2.07 2.70 H3034f12 2.07 7.68 H3042B02 2.07 3.24 H3152F03 2.07 2.30 BG072156 Interferon induced transmembrane protein 3 Ifitm3 2.06 2.39 BG086752 Gem (nuclear organelle) associated protein 4 Gemin4 2.06 6.89 BG077096 Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme Gcnt2 2.05 1.28 BG064126 Solute carrier family 2 (facilitated glucose transporter), member 1 Slc2a1 2.04 10.95 H3019b12 2.04 0.06 H3149C04 2.04 9.73 AW542365 Villin 2 Vil2 2.03 6.18 H3055H04 2.03 2.16 H3031G09 2.03 2.65 H3130F02 2.01 5.10 BG082002 2.01 2.14 BG087417 2.01 3.40 BG074351 LIM and cysteine-rich domains 1 Lmcd1 2.00 6.86 H3036D07 2.00 8.34 BG072874 Secreted acidic cysteine rich glycoprotein Sparc 2.00 3.34 BG082154 1.99 1.22 H3063A04 1.99 1.23 H3032D06 1.99 4.31 BG077685 Transcribed locus, strongly similar to XP_424503.1 type II alpha keratin IIA [Gallus gallus] 1.98 3.78 H3017A03 1.98 1.33 H3143d11 1.98 2.25 H3081B06 1.98 3.27 H3009E03 1.98 2.28 BG079988 Creatine kinase, mitochondrial 1, ubiquitous Ckmt1 1.97 6.38 H3072B09 1.97 4.22 H3132F04 1.97 7.70 BG074893 WAP four-disulfide core domain 1 Wfdc1 1.97 4.05 H3143D04 1.97 0.09 H3020H02 1.96 0.84 H3071e10 1.96 3.42 BG079235 Cellular repressor of E1A-stimulated genes 1 Creg1 1.96 0.93 BG067648 1.96 4.33 BG088827 Interleukin 18 Il18 1.96 3.76 H3047C02 1.96 3.95 H3108F06 1.96 3.64 BG086572 PR domain containing 16 Prdm16 1.95 4.39 BG073021 RIKEN cDNA 6720464I07 gene Trio 1.95 4.31 C80586 Syndecan 4 Sdc4 1.95 3.36 H3046B03 1.95 2.68 H3050D06 1.95 1.04 H3043G01 1.94 1.91 BG079186 Endothelial differentiation, lysophosphatidic acid G-protein-coupled rece Edg2 1.94 9.18 BG080562 1.94 2.07 H3039G07 1.93 0.08 BG079181 1.93 4.56 H3112E05 1.93 3.50 BG072629 RIKEN cDNA 5730411O18 gene 5730411O18Rik 1.93 1.80 BG063860 1.93 1.95 H3076H07 1.93 1.61 H3051D01 1.93 1.16 H3002A07 1.93 5.04 H3031F06 1.92 6.95 H3071f11 1.92 3.54 H3035G03 1.92 0.94 BG088014 Protein tyrosine phosphatase, receptor type, F Ptprf 1.92 0.09 BG070042 Sorbitol dehydrogenase 1 Sdh1 1.92 2.32 BG073090 G two S phase expressed protein 1 Gtse1 1.92 0.13 H3047D08 1.91 5.38 H3081D05 1.91 3.19 H3014h11 1.91 1.78 H3019D03 1.91 2.49 H3106d10 1.91 0.21 H3018h10 1.91 0.95 BG078028 Lectin, galactose binding,
Load more

Recommended publications
  • Molecular, Genetic, and Nutritional Aspects of Major and Trace Minerals
    Molecular, Genetic, and Nutritional Aspects of Major and Trace Minerals Edited by James F. Collins AMSTERDAM • BOSTON • HEIDELBERG • LONDON • NEW ORK • OFORD • PARIS SAN DIEGO • SAN FRANCISCO • SINGAPORE • SDNE • TOKO Academic Press is an imprint of Elsevier Academic Press is an imprint of Elsevier 125 London Wall, London EC2Y 5AS, United Kingdom 525 B Street, Suite 1800, San Diego, CA 92101-4495, United States 50 Hampshire Street, 5th Floor, Cambridge, MA 02139, United States The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom Copyright © 2017 Elsevier Inc. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher. Details on how to seek permission, further information about the Publisher’s permissions policies and our arrangements with organizations such as the Copyright Clearance Center and the Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions. This book and the individual contributions contained in it are protected under copyright by the Publisher (other than as may be noted herein). Notices Knowledge and best practice in this field are constantly changing. As new research and experience broaden our understanding, changes in research methods, professional practices, or medical treatment may become necessary. Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds, or experiments described herein. In using such information or methods they should be mindful of their own safety and the safety of others, including parties for whom they have a professional responsibility.
    [Show full text]
  • Multi-Ancestry Genome-Wide Gene-Sleep Interactions Identify Novel
    bioRxiv preprint doi: https://doi.org/10.1101/2020.05.29.123505; this version posted May 31, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Multi-ancestry genome-wide gene-sleep interactions identify novel loci for blood pressure Heming Wang1,2,*, Raymond Noordam3,* , Brian E Cade1,2,*, Karen Schwander4,*, Thomas W Winkler5,*, Jiwon Lee1,*, Yun Ju Sung4,*, Amy R. Bentley6,*, Alisa K Manning2,7, Hugues Aschard8,9, Tuomas O Kilpeläinen10,11, Marjan Ilkov12, Michael R Brown13, Andrea R Horimoto14, Melissa Richard15, Traci M Bartz16, Dina Vojinovic17,18, Elise Lim19, Jovia L Nierenberg20, Yongmei Liu21, Kumaraswamynaidu Chitrala22, Tuomo Rankinen23, Solomon K Musani24, Nora Franceschini25, Rainer Rauramaa26, Maris Alver27,28, Phyllis Zee29, Sarah E Harris30, Peter J van der Most31, Ilja M Nolte31, Patricia B Munroe32,33, Nicholette D Palmer34, Brigitte Kühnel35,36, Stefan Weiss37,38, Wanqing Wen39, Kelly A Hall40, Leo-Pekka Lyytikäinen41,42, Jeff O'Connell43,44, Gudny Eiriksdottir12, Lenore J Launer22, Paul S de Vries13, Dan E Arking45, Han Chen13,46, Eric Boerwinkle13,47, Jose E Krieger14, Pamela J Schreiner48, Stephen S Sidney49, James M Shikany50, Kenneth Rice51, Yii-Der Ida Chen52, Sina A Gharib53, Joshua C Bis54, Annemarie I Luik17, M Arfan Ikram17,55, André G Uitterlinden17, Najaf Amin17, Hanfei Xu19, Daniel Levy19,56, Jiang He20, Kurt
    [Show full text]
  • Proteomic Analyses Reveal a Role of Cytoplasmic Droplets As an Energy Source During Sperm Epididymal Maturation
    Proteomic analyses reveal a role of cytoplasmic droplets as an energy source during sperm epididymal maturation Shuiqiao Yuana,b, Huili Zhenga, Zhihong Zhengb, Wei Yana,1 aDepartment of Physiology and Cell Biology, University of Nevada School of Medicine, Reno, NV, 89557; and bDepartment of Laboratory Animal Medicine, China Medical University, Shenyang, 110001, China Corresponding author. Email: [email protected] Supplemental Information contains one Figure (Figure S1), three Tables (Tables S1-S3) and two Videos (Videos S1 and S2) files. Figure S1. Scanning electron microscopic images of purified murine cytoplasmic droplets. Arrows point to indentations resembling the resealed defects at the detaching points when CDs come off the sperm flagella. Scale bar = 1µm Table S1 Mass spectrometry-based identifiaction of proteins highly enriched in murine cytoplasmic droplets. # MS/MS View:Identified Proteins (105) Accession Number Molecular Weight Protein Grouping Ambiguity Dot_1_1 Dot_2_1 Dot_3_1 Dot_4_1Dot_5_1 Dot_1_2 Dot_2_2 Dot_3_2 Dot_4_2 Dot_5_2 1 IPI:IPI00467457.3 Tax_Id=10090 Gene_Symbol=Ldhc L-lactate dehydrogenase C chain IPI00467457 36 kDa TRUE 91% 100% 100% 100% 100% 100% 100% 100% 100% 2 IPI:IPI00473320.2 Tax_Id=10090 Gene_Symbol=Actb Putative uncharacterized protein IPI00473320 42 kDa TRUE 75% 100% 100% 100% 100% 89% 76% 100% 100% 100% 3 IPI:IPI00224181.7 Tax_Id=10090 Gene_Symbol=Akr1b7 Aldose reductase-related protein 1 IPI00224181 36 kDa TRUE 100% 100% 76% 100% 100% 4 IPI:IPI00228633.7 Tax_Id=10090 Gene_Symbol=Gpi1 Glucose-6-phosphate
    [Show full text]
  • Regulation of Cardiac Progenitors by Combination of Mesp1 and ETS
    REGULATION OF CARDIAC PROGENITORS BY COMBINATION OF MESP1 AND ETS TRANSCRIPTION FACTORS A Dissertation by KUO-CHAN WENG Submitted to the Office of Graduate and Professional Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Chair of Committee, Fen Wang Co-Chair of Committee, Robert J. Schwartz Committee Members, James F. Martin Jiang Chang Head of Department, Fen Wang May 2014 Major Subject: Medical Science Copyright 2014 Kuo-Chan Weng ABSTRACT Heart disease remains the leading cause of death worldwide. By understanding the regulating networks during cardiac development we can exploit those networks to manipulate adult cells into cardiac progenitors and provide an alternative for repairing diseased hearts. Mesp1 is considered to have critical roles during cardiac development but the molecular mechanisms need to be further studied. The roles of ETS transcription factors have been primarily limited to hematopoietic differentiation and cancer progression. The ETS transcription factors are known to have proliferating roles and were hypothesized to also be involved in cardiac differentiation and may potentially be used for cell reprogramming. The first part of this study characterizes the expression pattern of Mesp1 protein in early mouse embryo from E6.5 to E9.5 and provides a full expression profile in differentiating embryoid bodies in vitro from the undifferentiated stage to Day10. Our work showed Mesp1 expresses in the posterior region of E6.5 embryo then starts migrating through the primitive streak toward anterior mesoderm and endoderm in E7.5. A Mesp1 linage tracing ES cell line was established, and it allowed us to trace the Mesp1 derived cell population.
    [Show full text]
  • Detailed Review Paper on Retinoid Pathway Signalling
    1 1 Detailed Review Paper on Retinoid Pathway Signalling 2 December 2020 3 2 4 Foreword 5 1. Project 4.97 to develop a Detailed Review Paper (DRP) on the Retinoid System 6 was added to the Test Guidelines Programme work plan in 2015. The project was 7 originally proposed by Sweden and the European Commission later joined the project as 8 a co-lead. In 2019, the OECD Secretariat was added to coordinate input from expert 9 consultants. The initial objectives of the project were to: 10 draft a review of the biology of retinoid signalling pathway, 11 describe retinoid-mediated effects on various organ systems, 12 identify relevant retinoid in vitro and ex vivo assays that measure mechanistic 13 effects of chemicals for development, and 14 Identify in vivo endpoints that could be added to existing test guidelines to 15 identify chemical effects on retinoid pathway signalling. 16 2. This DRP is intended to expand the recommendations for the retinoid pathway 17 included in the OECD Detailed Review Paper on the State of the Science on Novel In 18 vitro and In vivo Screening and Testing Methods and Endpoints for Evaluating 19 Endocrine Disruptors (DRP No 178). The retinoid signalling pathway was one of seven 20 endocrine pathways considered to be susceptible to environmental endocrine disruption 21 and for which relevant endpoints could be measured in new or existing OECD Test 22 Guidelines for evaluating endocrine disruption. Due to the complexity of retinoid 23 signalling across multiple organ systems, this effort was foreseen as a multi-step process.
    [Show full text]
  • Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1
    bioRxiv preprint doi: https://doi.org/10.1101/2020.05.22.109017; this version posted May 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Assessment of NR4A Ligands that Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1 Paola Munoz-Tello 1, Hua Lin 2,3, Pasha Khan 2, Ian Mitchelle S. de Vera 1,4, Theodore M. Kamenecka 2, and Douglas J. Kojetin 1,2,* 1 Department of Integrative Structural and Computational Biology, The Scripps Research Institute, Jupiter, FL, 33458, USA 2 Department of Molecular Medicine, The Scripps Research Institute, Jupiter, Florida 33458, USA 3 Current address: Biomedical Research Center of South China, College of Life Sciences, Fujian Normal University, Fuzhou 350117, China 4 Current address: Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA * Correspondence: [email protected] as ligands that increase Nurr1 transcription in human neuroblastoma SK- ABSTRACT N-BE(2)-C cells (11). Amodiaquine improves behavioral alterations in a Nurr1/NR4A2 is an orphan nuclear receptor transcription factor im- Parkinson’s disease animal model (11) and improves neuropathology and plicated as a potential drug target for neurological disorders including memory impairment in an Alzheimer’s disease animal model (12). Alzheimer’s and Parkinson’s diseases. Previous studies identified small molecule modulators of NR4A nuclear receptors including Nurr1 and Amodiaquine is the most potent and efficacious Nurr1 agonist of the Nur77/NR4A1; it remains unclear whether these ligands affect Nurr1 4-amino-7-chloroquinoline compounds, but these compounds are not through direct binding or indirect non-binding mechanisms.
    [Show full text]
  • Table 2. Significant
    Table 2. Significant (Q < 0.05 and |d | > 0.5) transcripts from the meta-analysis Gene Chr Mb Gene Name Affy ProbeSet cDNA_IDs d HAP/LAP d HAP/LAP d d IS Average d Ztest P values Q-value Symbol ID (study #5) 1 2 STS B2m 2 122 beta-2 microglobulin 1452428_a_at AI848245 1.75334941 4 3.2 4 3.2316485 1.07398E-09 5.69E-08 Man2b1 8 84.4 mannosidase 2, alpha B1 1416340_a_at H4049B01 3.75722111 3.87309653 2.1 1.6 2.84852656 5.32443E-07 1.58E-05 1110032A03Rik 9 50.9 RIKEN cDNA 1110032A03 gene 1417211_a_at H4035E05 4 1.66015788 4 1.7 2.82772795 2.94266E-05 0.000527 NA 9 48.5 --- 1456111_at 3.43701477 1.85785922 4 2 2.8237185 9.97969E-08 3.48E-06 Scn4b 9 45.3 Sodium channel, type IV, beta 1434008_at AI844796 3.79536664 1.63774235 3.3 2.3 2.75319499 1.48057E-08 6.21E-07 polypeptide Gadd45gip1 8 84.1 RIKEN cDNA 2310040G17 gene 1417619_at 4 3.38875643 1.4 2 2.69163229 8.84279E-06 0.0001904 BC056474 15 12.1 Mus musculus cDNA clone 1424117_at H3030A06 3.95752801 2.42838452 1.9 2.2 2.62132809 1.3344E-08 5.66E-07 MGC:67360 IMAGE:6823629, complete cds NA 4 153 guanine nucleotide binding protein, 1454696_at -3.46081884 -4 -1.3 -1.6 -2.6026947 8.58458E-05 0.0012617 beta 1 Gnb1 4 153 guanine nucleotide binding protein, 1417432_a_at H3094D02 -3.13334396 -4 -1.6 -1.7 -2.5946297 1.04542E-05 0.0002202 beta 1 Gadd45gip1 8 84.1 RAD23a homolog (S.
    [Show full text]
  • Glycoproteomics-Based Signatures for Tumor Subtyping and Clinical Outcome Prediction of High-Grade Serous Ovarian Cancer
    ARTICLE https://doi.org/10.1038/s41467-020-19976-3 OPEN Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer Jianbo Pan 1,2,3, Yingwei Hu1,3, Shisheng Sun 1,3, Lijun Chen1, Michael Schnaubelt1, David Clark1, ✉ Minghui Ao1, Zhen Zhang1, Daniel Chan1, Jiang Qian2 & Hui Zhang 1 1234567890():,; Inter-tumor heterogeneity is a result of genomic, transcriptional, translational, and post- translational molecular features. To investigate the roles of protein glycosylation in the heterogeneity of high-grade serous ovarian carcinoma (HGSC), we perform mass spectrometry-based glycoproteomic characterization of 119 TCGA HGSC tissues. Cluster analysis of intact glycoproteomic profiles delineates 3 major tumor clusters and 5 groups of intact glycopeptides. It also shows a strong relationship between N-glycan structures and tumor molecular subtypes, one example of which being the association of fucosylation with mesenchymal subtype. Further survival analysis reveals that intact glycopeptide signatures of mesenchymal subtype are associated with a poor clinical outcome of HGSC. In addition, we study the expression of mRNAs, proteins, glycosites, and intact glycopeptides, as well as the expression levels of glycosylation enzymes involved in glycoprotein biosynthesis pathways in each tumor. The results show that glycoprotein levels are mainly controlled by the expression of their individual proteins, and, furthermore, that the glycoprotein-modifying glycans cor- respond to the protein levels of glycosylation enzymes. The variation in glycan types further shows coordination to the tumor heterogeneity. Deeper understanding of the glycosylation process and glycosylation production in different subtypes of HGSC may provide important clues for precision medicine and tumor-targeted therapy.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Overexpressed Nup88 Stabilized Through Interaction with Nup62 Promotes NFB
    bioRxiv preprint doi: https://doi.org/10.1101/2020.04.27.063057; this version posted May 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Overexpressed Nup88 stabilized through interaction with Nup62 promotes NFB dependent pathways in cancer Usha Singh1, Atul Samaiya2, and Ram Kumar Mishra1,* 1 Nups and Sumo Biology Group, Department of Biological Sciences, Indian Institute of Science Education and Research (IISER) Bhopal, Madhya Pradesh, 462066, India. 2 Department of Surgical Oncology, Bansal Hospital, Bhopal, Madhya Pradesh, 462016, India * To whom correspondence should be addressed. Corresponding Author: Phone – +91-755-2691407 Fax - +91-755-2692392 Email- [email protected] Keywords Nup88; NFB; Head and neck cancer; ubiquitination; cell proliferation; inflammation 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.04.27.063057; this version posted May 4, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Nuclear pores control nucleo-cytoplasmic trafficking and directly or indirectly regulate vital cellular processes. Nup88, important for Crm1 mediated nuclear export process, is overexpressed in many cancers. A positive correlation exists between progressive stages of cancer and Nup88 expression. However, links between Nup88 overexpression and head and neck cancer are insignificant, and mechanistic details are non-existent. Here, we report that Nup88 exhibits positive correlation in head and neck cancer in addition to elevated Nup62 levels. We demonstrate that Nup88 interacts with Nup62 in a cell-cycle and glycosylation independent manner.
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • Supplementary Table 3
    Supplemental Table 1 M e13 ∆∆Ct e13 M e15 ∆∆Ct e15 chromogranin A -3,26 (9,6 ↓ ) -6,29 (78 ↓ ) -2,56 (5,9 ↓ ) -6,57 (95 ↓ ) crystallin, beta A2 -0,95 (1,9 ↓ ) -4,57 (24 ↓ ) -1,82 (3,5 ↓ ) -4 (16 ↓ ) cyclin-dependent kinase inhibitor 1A (P21) -1,15 (2,2 ↓ ) -1,41 (2,7 ↓ ) -0,36 (1,3 ↓ ) 0,29 (1,2 ↑ ) cytochrome P450, family 4, subfamily b, polypeptide 1 -0,68 (1,6 ↓ ) 0,16 (1,1 ↑ ) -0,56 (1,5 ↓ ) -0,08 (1,1 ↓ ) myelin transcription factor 1 -1,28 (2,4 ↓ ) -2,62 (6,1 ↓ ) -1,46 (2,8 ↓ ) -3,59 (12 ↓ ) neurogenic differentiation 2 -0,06 (1,0 → ) NA -1,34 (2,5 ↓ ) NA neuronatin 0,14 (1,1 ↑ ) 0,12 (1,1 ↑ ) -0,79 (1,7 ↓ ) -2,02 (4,1 ↓ ) protocadherin 21 -1,62 (3,1 ↓ ) -5,71 (52 ↓ ) -1,77 (3,4 ↓ ) -6,41 (85 ↓ ) regulated endocrine-specific protein 18 -2,1 (4,3 ↓ ) -4,73 (27 ↓ ) -1,55 (2,9 ↓ ) -5,09 (34 ↓ ) retinol binding protein 4, plasma -1,68 (3,2 ↓ ) -1,52 (2,9 ↓ ) -1,53 (2,9 ↓ ) -2,15 (4,4 ↓ ) rhomboid, veinlet-like 4 (Drosophila) -1,14 (2,2 ↓ ) -0,29 (1,2 ↓ ) -1,09 (2,1 ↓ ) -0,58 (1,5 ↓ ) sestrin 2 -0,78 (1,7 ↓ ) -0,84 (1,8 ↓ ) -0,67 (1,6 ↓ ) -0,61 (1,5 ↓ ) synaptotagmin 13 -1,63 (3,1 ↓ ) -2,59 (6,0 ↓ ) -1,77 (3,4 ↓ ) -2,71 (6,5 ↓ ) t-complex protein 11 -0,48 (1,4 ↓ ) -1,35 (2,5 ↓ ) -0,68 (1,6 ↓ ) -2,83 (7,1 ↓ ) -0,62 (1,5 ↓ ) -0,76 (1,7 ↓ ) transmembrane 4 superfamily member 2 -0,29 (1,2 ↓ ) -0,55 (1,5 ↓ ) -0,67 (1,6 ↓ ) -0,38 (1,3 ↓ ) 2510004L01Rik -0,7 (1,6 ↓ ) -1,58 (3,0 ↓ ) -0,07 (1,0 → ) 0,16 (1,1 ↑ ) C81234 -3,12 (8,7 ↓ ) -7,75 (215 ↓ ) -2,29 (4,9 ↓ ) -4,86 (29 ↓ ) Insulin 2 NM -9,89 (948 ↓ ) NM -14,2 (18820 ↓ ) Neurogenin 3 NM NA
    [Show full text]